Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors. [electronic resource]
Producer: 20010614Description: 1106-12 p. digitalISSN:- 0022-3565
- Animals
- Antineoplastic Agents -- administration & dosage
- Bone Marrow -- chemistry
- Carcinoma, Hepatocellular -- chemistry
- Cisplatin -- administration & dosage
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Injections, Intraperitoneal
- Kidney -- chemistry
- Kidney Function Tests
- Liver -- chemistry
- Liver Neoplasms, Experimental -- chemistry
- Male
- Mice
- Mice, Nude
- Myocardium -- chemistry
- Neoplasm Transplantation
- Neural Conduction -- drug effects
- Organoplatinum Compounds -- administration & dosage
- Platinum -- analysis
- Rats
- Rats, Wistar
- Sciatic Nerve -- chemistry
- Survival Rate
- Tissue Distribution
- Tumor Cells, Cultured
- Ursodeoxycholic Acid -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.